new_0222_0473|FDMT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0473|FDMT|1|4D Molecular Therapeutics Inc Total Current Assets (Quarterly) (USD)|4D Molecular Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|4D Molecular Therapeutics Inc Inventories (Quarterly) (USD)|4D Molecular Therapeutics Inc Net PP&E (Quarterly) (USD)|4D Molecular Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Deposits (Quarterly) (USD)|4D Molecular Therapeutics Inc Book Value (Quarterly) (USD)|4D Molecular Therapeutics Inc Retained Earnings (Quarterly) (USD)|4D Molecular Therapeutics Inc Treasury Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc EV to Revenues|4D Molecular Therapeutics Inc EV to Earnings|4D Molecular Therapeutics Inc EV to Free Cash Flow|4D Molecular Therapeutics Inc EV to Assets (Quarterly)|4D Molecular Therapeutics Inc PS Ratio|4D Molecular Therapeutics Inc PE Ratio|4D Molecular Therapeutics Inc Price to Book Value|4D Molecular Therapeutics Inc PEG Ratio|4D Molecular Therapeutics Inc Debt to Equity Ratio|4D Molecular Therapeutics Inc Dividend Yield|4D Molecular Therapeutics Inc Shareholder Yield (TTM)|4D Molecular Therapeutics Inc Percent of Shares Outstanding Short|4D Molecular Therapeutics Inc Total Receivables (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Payables (Quarterly) (USD)|4D Molecular Therapeutics Inc Total Capital Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc Return on Invested Capital|4D Molecular Therapeutics Inc Quality Ratio Score|4D Molecular Therapeutics Inc Momentum Score|4D Molecular Therapeutics Inc Beta (1Y)|4D Molecular Therapeutics Inc Sustainable Growth Rate (TTM)|4D Molecular Therapeutics Inc Institutional Investor Ownership Percentage|4D Molecular Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|4D Molecular Therapeutics Inc Total Employees (Annual)|4D Molecular Therapeutics Inc EPS Diluted (Quarterly) (USD)|4D Molecular Therapeutics Inc Shares Outstanding|4D Molecular Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|4D Molecular Therapeutics Inc Ordinary Shares Number (Quarterly)|4D Molecular Therapeutics Inc Payout Ratio|4D Molecular Therapeutics Inc Quick Ratio (Quarterly)|4D Molecular Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|4D Molecular Therapeutics Inc Stock Buybacks (Quarterly) (USD)|4D Molecular Therapeutics Inc Effective Tax Rate (TTM)|4D Molecular Therapeutics Inc Return on Equity|4D Molecular Therapeutics Inc Net Income (TTM) (USD)|4D Molecular Therapeutics Inc Revenue (TTM) (USD)|4D Molecular Therapeutics Inc Dividend Per Share (Quarterly) (USD)|4D Molecular Therapeutics Inc Revenue (Quarterly) (USD)|4D Molecular Therapeutics Inc Gross Profit (Quarterly) (USD)|4D Molecular Therapeutics Inc SG&A Expense (Quarterly) (USD)|4D Molecular Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Net Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Net Interest Income (Quarterly) (USD)|4D Molecular Therapeutics Inc Price (USD)|4D Molecular Therapeutics Inc Total Return Price (USD)|4D Molecular Therapeutics Inc Enterprise Value (USD)|4D Molecular Therapeutics Inc 30-Day Average Daily Volume|4D Molecular Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0473|FDMT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0473|FDMT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0473|FDMT|5|143.428571429|143.428571429|0|143.428571429|0|143.428571429|143.428571429|143.428571429|0|143.428571429|143.428571429|0|1.45302013423|91|1.44912280702|91|1.45150501672|0|1.45150501672|0|91.2857142857|1.45302013423|0|15.2592592593|143.428571429|143.428571429|143.428571429|91|0|0|31|91|30.4615384615|91.375|121.666666667|91.375|27.9166666667|0|143.428571429|91.4|91.2857142857|91.375|0|0|91|91.4|91.4|0|91.375|0|91.375|91.375|91.375|91.375|1.45150501672|1.45150501672|1.45302013423|1.43866171004|1.4347826087||
new_0222_0473|FDMT|6|7|7|0|7|0|7|7|7|0|7|7|0|298|3|285|3|299|0|299|0|7|298|0|27|7|7|7|3|0|0|1|3|13|8|3|8|12|0|7|5|7|8|0|0|3|5|5|0|8|0|8|8|8|8|299|299|298|269|46||
new_0222_0473|FDMT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0473|FDMT|201812|94.068|91.761||2.472||124.556|8.054|116.502||-27.587|-30.026||||||||||||||1.124|0.954|0.001||||||||||||21.5956||||||||||||||||||||||
new_0222_0473|FDMT|201906|75.445|72.869||4.026||122.804|8.603|114.201||-42.304|-46.235||||||||||||||1.161|1.296|0.001||||||||||||21.5956||||||||||||||||||||||
new_0222_0473|FDMT|201909||||||||||||||||||||||||||||||||||14.8353||-1.124||||||-1.124|||||||0.54||3.052|-16.675|-16.675|0.341|||||||
new_0222_0473|FDMT|201912|52.508|49.652||5.049||131.204|12.955|118.249||-72.97|-79.025||||||||||0||||0.978|1.744|0.001|||||||14.8353||-1.0863|||21.5956||3.9081|-1.0863|||||||2.03||5.959|-16.115|-16.115|0.218|||||||
new_0222_0473|FDMT|202003||||||||||||||||||||||||||||||||||14.8353||-0.8871||||||-0.8871|||||||3.535||3.654|-13.16|-13.16|0.13|||||||
new_0222_0473|FDMT|202006||||||||||||||||||||||||||||||||||14.8353||-1.0214||||0||-1.0214||||-61.103|9.738||3.633||3.062|-15.153|-15.153|0.014|||||||
new_0222_0473|FDMT|202009|92.536|88.755||4.981||28.036|14.278|13.758||70.156|-115.132||||||||||0||||0.896|1.292|0.002|||||||21.5956|78|-0.3627|||21.5956|0|6.279|-0.3627||||-52.261|16.619||7.421||3.682|-7.833|-7.833|0.004|||||||
new_0222_0473|FDMT|202012|282.656|276.726||5.073||31.944|16.744|15.2||256.387|-135.679||60.92|-14.6269|-15.9749|2.876|59.3402||16.2272||0|0||0.5961|1.486|1.787|0.003|-67.073||||-154.3238|77.0587|26.682|83|-0.7701|26.682||26.682|0|16.6156|-0.7701|||-154.3238|-56.693|13.612||-0.977||6.84|-20.547|-20.547|0.004|41.45|41.45|829.2429|281224.4667||42|43.29
new_0222_0473|FDMT|202103|264.501|259.865||5.011||27.683|13.916|13.767||242.431|-152.085||74.3676|-14.9842|-16.8405|3.325|56.5915||4.0137||0|0||2.8141|0.965|1.284|0.003|-31.6037||||-66.0558|85.1058|26.6902||-0.61|26.6944||26.6944|0|18.7432|-0.61|||-66.0558|-59.939|12.077||2||5.543|-16.406|-16.406|0.007|39.53|39.53|778.4443|200681.6||38.36|27.02
new_0222_0473|FDMT|202106|248.752|243.743||5.58||14.288|9.87|4.418||240.646|-159.674||17.5388|-7.7101|-6.3111|1.584|41.2691||2.5926||0|0||3.5223|1.218|1.962|0.003|-25.8763||||-35.5494|94.0139|26.7391|104|-0.28|26.8919||26.8919|0|24.8187|-0.28|||-35.5494|-52.375|23.024||14.58||6.953|-7.589|-7.589|0.007|22.2|22.2|333.8918|151592.9667||25.17|31.21
new_0222_0473|FDMT|202109|165.733|161.675||8.789||16.484|11.373|5.111||224.134|-181.913||33.6485|-8.5501|-8.237|2.373|42.5687||3.4071||0|0||5.9039|0.791|3.713|0.003|-32.3002||||-32.3002|96.1738|27.0224|121|-0.82|27.1656||27.1656|0|14.2852|-0.82|||-32.3002|-66.781|16.969||1.366||8.187|-22.239|-22.239|0.435|26.97|26.97|570.9812|206674.8333||30.85|22.05
new_0222_0473|FDMT|202112||247.777||||34.38|||||||32.0261||-7.8398||34.4085||3.0886|||0||4.3477||||||2|0.5347||93.779|||-0.85|32.2245|||||||||-71.317|18.038||0.092||7.328||-25.083||21.8|21.8|538.9508|365225.0667|-47.0688|14.7|13.88
new_0222_0473|FDMT|202203||236.153||||28.87|||||||||||25.1345||1.6517|||||||||||||||||-0.82|32.2641|||||||||-81.249|17.257||1.219||8.23||-26.338||16.35|16.35|279.3061|207272.2667||11.87|7.59
new_0222_0473|FDMT|202206||241.088||||30.419|||||||||||75.0154||0.7746|||||||||||||||||-0.87|32.3769|||||||||-101.746|2.839||0.162||8.166||-28.086||7.1|7.1|-6.8244|354983.9333||10.71|8.25
new_0222_0473|FDMT|202209||227.715||||28.72|||||||||||88.3419||0.9898|||||||||||||||||-0.79|32.3924|||||||||-105.198|1.973||0.5||8.055||-25.691||8.33|8.33|28.6574|194856.1333||7.5|23.37
new_0222_0473|FDMT|202212||213.554||||30.509|||||||||||358.5583||2.6113|||||||||||||||||-0.84|32.6266|||||||||-107.494|3.128||1.247||8.467||-27.379||20.27|20.27|428.8789|736174.3||21.05|19.24
new_0222_0473|FDMT|202303||200.454||||25.415|||||||||||252.9885||2.4021|||||||||||||||||-0.88|33.2368||||||-9.647|||-109.838|2.207||0.298||7.992||-28.682||16.72|16.72|342.1469|436851.8||21.02|18.38
new_0222_0473|FDMT|202306||310.343||||27.359|||||||||||265.7925||3.4603|||||||||||||||||-0.77|42.0166||||||-129.72|||-111.368|2.284||0.239||8.791||-29.616||18.06|18.06|555.9963|643327.5667||17.98|16.71
new_0222_0473|FDMT|202309||319.664||||31.679|||||||||||193.7241||1.684|||||||||||||||||-0.24|42.7525||||||-8.976|||-95.933|21.988||20.204||9.112||-10.256||13.02|13.02|237.1871|327010||10.37|12.32
new_0222_0473|FDMT|202312||288.232||||32.062|||||||||||34.9792||2.7342|||||||||||||||||-0.77|43.0752||||||-0.001|||-100.837|20.722||-0.019||10.605||-32.283||21.1|21.1|582.437|377697.7333||17.25|27.89
new_0222_0473|FDMT|202403||525.911||||29.323|||||||||||67.5884||5.8004|||||||||||||||||-0.66|51.1574||||||-315.719|||-104.556|20.452||0.028||10.294||-32.401||35.87|35.87|1497.3084|845841.4667||24.25|23.96
new_0222_0473|FDMT|202406||541.946||||31.777|||||||||||44.192||1.8019|||||||||||||||||-0.63|51.9143||||||-15.692|||-109.893|20.218||0.005||10.601||-34.953||20.93|20.93|556.2412|565524.2||18.35|15.01
new_0222_0473|FDMT|202409||501.892||||51.08|||||||||||32267.2766||0.9566|||||||||||||||||-0.79|51.9966||||||-0.001|||-143.48|0.017||0.003||12.651||-43.843||10.83|10.83|20.8848|681784.3667||8.15|7.84
new_0222_0473|FDMT|202412||424.877||||49.778|||||||||||15820.2189||0.464|||||||||||||||||-0.9|45.7939|||||||||-160.868|0.037||0.001||13.031||-49.671||5.55|5.55|-245.3283|1006574.7||5.6|4.53
new_0222_0473|FDMT|202503||321.437||||46.006|||||||||||5386.4872||0.3292|||||||||||||||||-0.86|46.3246|||||||||-176.439|0.023||0.014||12.936||-47.972||3.63|3.63|-260.0405|738409.1333||3.24|3.42
new_0222_0473|FDMT|202506|||||||||||||||||9661.8741||0.3945||||||||||||||||||||||||||||||||||||4|4|-143.5505|465032.1||4.24|